Gene · 10298
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PAK4 exacerbates melanoma immunosuppression by promoting exosome release. | Proc Natl Acad Sci U S A | 2026 | 42826135 | PubTator, text mining | PubMed |
| Investigating the anti-TNBC potential of new quinazoline-based PAK4 inhibitors: design, synthesis and biological evaluation. | Eur J Med Chem | 2026 | 42800115 | PubTator, text mining | PubMed |
| PAK4-targeting PROTAC inhibits bladder cancer cell proliferation. | PLoS One | 2026 | 42766568 | PubTator, text mining | PubMed |
| Computational Identification of New Dual PAK4 and NAMPT Inhibitors. | Int J Mol Sci | 2026 | 42737604 | PubTator, text mining | PubMed |
| PAK4: A vanguard of epithelial vertex remodeling. | J Cell Biol | 2026 | 42606375 | PubTator, text mining | PubMed |
| Thiram inhibits human sperm motility and capacitation by increasing mitochondrial O2 - and reducing PTK and PAK4 activity at environmental concentrations. | Transl Androl Urol | 2026 | 42583012 | PubTator, text mining | PubMed |
| Targeting p21-activated kinase 4: Recent advances in the discovery of PAK4 inhibitors and strategies for isoform selectivity. | Eur J Med Chem | 2026 | 42546589 | PubTator, text mining | PubMed |
| Detergent selection as a determinant of protein melting behavior and drug-target interaction-calling in thermal stability proteomics. | bioRxiv | 2026 | 42539280 | PubTator, text mining | PubMed |
| p21-activated kinase 4 drives hepatic stellate cell activation and liver fibrosis through the phosphorylation of YAP at T428. | Signal Transduct Target Ther | 2026 | 42527392 | PubTator, text mining | PubMed |
| Phosphoproteomic Profiling Identifies PAK4 S474 Phosphorylation Affects Docetaxel Chemosensitivity via Modulation of Microtubule Stabilization in Breast Cancer. | Biomedicines | 2026 | 42512103 | PubTator, text mining | PubMed |
| PAK4 in the Tumor Immune Microenvironment: Biological Functions, Regulatory Mechanisms, and Targeted Therapeutic Strategies. | Med Res Rev | 2026 | 42489806 | PubTator, text mining | PubMed |
| Structural basis for a p21-activated kinase 4 and nicotinamide phosphoribosyltransferase dual inhibitor. | Acta Crystallogr D Struct Biol | 2026 | 42473948 | PubTator, text mining | PubMed |
| Single-cell and bulk transcriptomics identify senescence-related EMT transcriptional programs and a prognostic framework in pancreatic ductal adenocarcinoma. | BMC Gastroenterol | 2026 | 42420840 | PubTator, text mining | PubMed |
| Novel Insight into the Therapeutic Targets for Spinal Degenerative Diseases Gained by a Post-Genome-Wide Association Study. | Int J Med Sci | 2026 | 42328112 | PubTator, text mining | PubMed |
| Phosphosite-centric regulatory network of ATAD2 and its involvement in transcriptional networks. | Mol Genet Genomics | 2026 | 41964706 | PubTator, text mining | PubMed |
| Integrative phosphoproteomic analysis reveals co-regulatory phosphorylation networks of rhotekin in cancer progression. | Discov Oncol | 2026 | 41963591 | PubTator, text mining | PubMed |
| Senescence-Driven Remodeling Defines an Aggressive and Immunomodulatory Subtype of Endometriosis. | Aging Cell | 2026 | 41891132 | PubTator, text mining | PubMed |
| PAK4 functions as an immune suppressor by reprogramming the phosphatidylcholine metabolism of CD8 + T cells within the glioblastoma tumor microenvironment. | Oncogene | 2026 | 41872692 | PubTator, text mining | PubMed |
| Myofibroblast lineage mapping and inhibiting subretinal fibrosis by targeting SMAD3 and MRTF pathways via microRNA-24 functional study. | bioRxiv | 2026 | 41867749 | PubTator, text mining | PubMed |
| First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies. | Target Oncol | 2026 | 41824279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10298/papers